About this FactMed analysis covering adverse side effect reports of ACEBROFYLLINE patients who developed CYANOSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ACEBROFYLLINE reported CYANOSIS to the FDA. A total of 11 ACEBROFYLLINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACEBROFYLLINE and CYANOSIS. In doing so, we compare ACEBROFYLLINE with other drugs that cause CYANOSIS, to help you evaluate whether or not ACEBROFYLLINE causes CYANOSIS. Likewise, this page shows the most highly-reported side effects of ACEBROFYLLINE, so you can see if CYANOSIS ranks among ACEBROFYLLINE's most well-known side effects.
Summary Statistics
Reports of ACEBROFYLLINE causing CYANOSIS: 1
Reports of any side effect of ACEBROFYLLINE : 11
Percentage of ACEBROFYLLINE patients where CYANOSIS is a reported side effect: 9.0909%

FDA reports of any drug causing CYANOSIS : 8275
Average percentage for all medicated patients where CYANOSIS is reported as a complication: 0.0519%

Physician opinion on ACEBROFYLLINE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACEBROFYLLINE:
PRODUCTIVE COUGH ( 3 patients )
BRONCHIECTASIS ( 3 patients )
( 0 patients )
Drugs with high FDA adverse event association with CYANOSIS:

REMICADE (624 patients)
HEPARIN SODIUM INJECTION (505 patients)
PAXIL (485 patients)
ASPIRIN (444 patients)
ZOLOFT (405 patients)
ALBUTEROL (270 patients)
SYNAGIS (267 patients)
VITAMIN TAB (259 patients)
LASIX (250 patients)
ACETAMINOPHEN (247 patients)
FUROSEMIDE (246 patients)
FOLIC ACID (223 patients)
OMEPRAZOLE (202 patients)
DIGOXIN (202 patients)
PAROXETINE HCL (195 patients)
VIOXX (192 patients)
PREDNISONE (178 patients)
METHOTREXATE (175 patients)
COUMADIN (173 patients)
LORAZEPAM (167 patients)
PAXIL CR (163 patients)
OXYCONTIN (159 patients)
LISINOPRIL (155 patients)
PREDNISOLONE (153 patients)
ATENOLOL (152 patients)
NEXIUM (148 patients)
TYLENOL (147 patients)
TRAMADOL HCL (144 patients)
DIAZEPAM (137 patients)
PRENATAL VITAMINS (136 patients)
BENADRYL (136 patients)
HUMIRA (135 patients)
CLOZARIL (134 patients)
IBUPROFEN (134 patients)
POTASSIUM CHLORIDE (133 patients)
AMOXICILLIN (132 patients)
HYDROCHLOROTHIAZIDE (131 patients)
DEXAMETHASONE (130 patients)
FENTANYL (128 patients)
LEVOTHYROXINE SODIUM (122 patients)
MORPHINE (119 patients)
TYLENOL (CAPLET) (118 patients)
HEPARIN SODIUM (117 patients)
ZOFRAN (115 patients)
SPIRONOLACTONE (115 patients)
PLAVIX (113 patients)
ALLOPURINOL (111 patients)
CLONAZEPAM (109 patients)
ALPRAZOLAM (107 patients)
SYNTHROID (106 patients)
TRACLEER (104 patients)
CARBOPLATIN (104 patients)
SOLU-MEDROL (103 patients)
XANAX (102 patients)
ZANTAC (102 patients)
HEPARIN (100 patients)
MORPHINE SULFATE (100 patients)
MYOZYME (99 patients)
AVELOX (98 patients)
REGLAN (98 patients)
MULTI-VITAMINS (94 patients)
EFFEXOR (94 patients)
LIPITOR (93 patients)
PROPOFOL (93 patients)
NORVASC (93 patients)
SEROQUEL (92 patients)
ATIVAN (91 patients)
GAMMAGARD LIQUID (91 patients)
PERCOCET (91 patients)
METOPROLOL TARTRATE (91 patients)
PACLITAXEL (90 patients)
NEURONTIN (90 patients)
RISPERDAL (90 patients)
SIMVASTATIN (90 patients)
SINGULAIR (90 patients)
LYRICA (89 patients)
ADVAIR DISKUS 100/50 (89 patients)
PROZAC (89 patients)
RANITIDINE (88 patients)
WARFARIN SODIUM (88 patients)
VICODIN (88 patients)
PREVACID (87 patients)
ATROVENT (87 patients)
YASMIN (85 patients)
PREDNISONE TAB (84 patients)
LEXAPRO (81 patients)
XOLAIR (81 patients)
LOVENOX (81 patients)
TOPROL-XL (80 patients)
IRON (79 patients)
CLARITIN (79 patients)
AMBIEN (79 patients)
PROTONIX (78 patients)
DIOVAN (78 patients)
TEGRETOL (77 patients)
ONDANSETRON (77 patients)
FLUOROURACIL (77 patients)
DURAGESIC-100 (77 patients)
CEPHALEXIN (76 patients)
OXYGEN (76 patients)
ENALAPRIL MALEATE (75 patients)
ZYPREXA (75 patients)
CISPLATIN (74 patients)
DECADRON (74 patients)
ZITHROMAX (74 patients)
ROCEPHIN (73 patients)
AMITRIPTYLINE HCL (72 patients)
AUGMENTIN '125' (71 patients)
ZYRTEC (70 patients)
FERROUS SULFATE TAB (69 patients)
CYMBALTA (68 patients)
PARACETAMOL (68 patients)
CLOZAPINE (68 patients)
ALLEGRA (68 patients)
LAMOTRIGINE (68 patients)
VANCOMYCIN (67 patients)
STRATTERA (67 patients)
EFFEXOR XR (67 patients)
SEREVENT (66 patients)
CYCLOPHOSPHAMIDE (66 patients)
INSULIN (65 patients)
CAPTOPRIL (65 patients)
LEVAQUIN (65 patients)
ALDACTONE (64 patients)
MIRTAZAPINE (64 patients)
ZOLPIDEM (64 patients)
SPIRIVA (64 patients)
PRILOSEC (63 patients)
NITROGLYCERIN (63 patients)
RAMIPRIL (63 patients)
METFORMIN HCL (63 patients)
LORTAB (62 patients)
LANSOPRAZOLE (62 patients)
FLONASE (62 patients)
ULTRAVIST 300 (61 patients)
LIDOCAINE (61 patients)
CRESTOR (61 patients)
LAMICTAL (60 patients)
TAXOTERE (60 patients)
LANTUS (59 patients)
METRONIDAZOLE (59 patients)
KEPPRA (59 patients)
AZITHROMYCIN (59 patients)
VALPROATE SODIUM (59 patients)
OXYCODONE HCL (58 patients)
FOSAMAX (58 patients)
CELEBREX (58 patients)
PHENERGAN HCL (57 patients)
NIFEDIPINE (57 patients)
PROPRANOLOL (57 patients)
VOLTAREN (56 patients)
CELEXA (56 patients)
ATARAX (55 patients)
FLEXERIL (55 patients)
FLUCONAZOLE (54 patients)
GABAPENTIN (54 patients)
TOPAMAX (54 patients)
MAGNESIUM SULFATE (54 patients)
MEDROL (54 patients)
CARBAMAZEPINE (53 patients)
DIPRIVAN (53 patients)
GLEEVEC (53 patients)
KYTRIL (53 patients)
COREG (53 patients)
MIDAZOLAM HCL (52 patients)
CITALOPRAM HYDROBROMIDE (51 patients)
AVASTIN (50 patients)
ZOCOR (50 patients)
ZOMETA (49 patients)
GLUCOPHAGE (49 patients)
SANDOSTATIN LAR (49 patients)
HYDROCORTISONE (48 patients)
AMLODIPINE (48 patients)
WELLBUTRIN (47 patients)
MULTI-VITAMIN (47 patients)
FAMOTIDINE (47 patients)
ERBITUX (47 patients)
BACTRIM (47 patients)
CONCERTA (47 patients)
TRAZODONE HCL (46 patients)
VITAMIN B-12 (46 patients)
FLOVENT (46 patients)
VENTOLIN (46 patients)
DURAGESIC (46 patients)
GEMZAR (46 patients)
TYSABRI (46 patients)
CARVEDILOL (46 patients)
PROMETHAZINE (45 patients)
PANTOPRAZOLE (45 patients)
VERAPAMIL (44 patients)
MOTRIN (44 patients)
HALOPERIDOL (44 patients)
VITAMIN D (44 patients)
SUDAFED 12 HOUR (44 patients)
QUETIAPINE (44 patients)
CLONIDINE (44 patients)
PHENERGAN (43 patients)
CIPROFLOXACIN (43 patients)
CALCIUM CARBONATE (43 patients)
PEPCID (43 patients)
TAXOL (43 patients)
COMBIVENT (43 patients)
AFINITOR (43 patients)
DOMPERIDONE (43 patients)
RISPERIDONE (43 patients)
OXALIPLATIN (42 patients)
MAGNEVIST (42 patients)
RITALIN (42 patients)
LEVETIRACETAM (42 patients)
EPINEPHRINE (42 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACEBROFYLLINE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about CYANOSIS and ACEBROFYLLINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACEBROFYLLINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACEBROFYLLINE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACEBROFYLLINE experts. If you are a healthcare provider experienced in prescribing ACEBROFYLLINE, please register here.

Your online appointment book for San Juan Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use